Related Experiment Video
Updated: Aug 6, 2026

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
Published on: April 17, 2013
Steroid/thyroid receptor-like proteins with oncogenic potential: a review
1Division of Tumor Biology, The Netherlands Cancer Institute, Amsterdam.
Abstract:
Mutated or truncated forms of certain members of the steroid/thyroid receptor superfamily have oncogenic potential. The aberrant forms compete with the normal receptor for binding to the responsive element on the DNA and thus interfere negatively with the normal transcription control mechanism. Oncogenes that arise from dominant negative mutations may therefore be called "dononcs," to distinguish them from recessive types such as that causing retinoblastoma ("renoncs"). It is possible that dononcs are also responsible for the loss of hormonal responsiveness of some tumors during progression.
Insights
Mutated steroid/thyroid receptors can act as oncogenes, termed "dononcs," by disrupting normal gene transcription. These aberrant proteins may also cause tumors to lose hormonal responsiveness during progression.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- Certain members of the steroid/thyroid receptor superfamily can exhibit oncogenic potential when mutated or truncated.
- Aberrant receptor forms interfere with normal transcriptional control by competing for DNA binding sites.
Purpose of the Study:
- To introduce and define the term "dononcs" for oncogenes arising from dominant-negative mutations.
- To explore the potential role of these "dononcs" in tumor progression and loss of hormonal responsiveness.
Main Methods:
- Conceptual analysis of receptor function and mutation.
- Comparison with recessive oncogenes (e.g., retinoblastoma).
Main Results:
- Mutated/truncated receptors can function as dominant-negative oncogenes ("dononcs").
- "Dononcs" disrupt normal transcription by interfering with DNA binding of normal receptors.
- These oncogenes may contribute to acquired hormone resistance in tumors.
Conclusions:
- Dominant-negative mutations in steroid/thyroid receptors can create oncogenes ("dononcs").
- "Dononcs" represent a distinct class of oncogenes with implications for cancer development and treatment resistance.
Related Concept Videos
Intracellular Hormone Receptors
Mitogens and the Cell Cycle
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Receptor Tyrosine Kinases
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...

